Atara Biotherapeutics ATRA
NASDAQ ATRA
$9.70 +0.32 (+3.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) Cash from Operations (2013 - 2026)

Atara Biotherapeutics' (ATRA) quarterly Cash from Operations came in at 3073000.0 in Q1 2026, up 89.08% YoY from 1625248.09 in Q1 2025, and up 46.06% on a QoQ basis from 5697000.0 in Q4 2025.

Atara Biotherapeutics (ATRA) Cash from Operations (2013 - 2026) Analysis & Trends

Atara Biotherapeutics (ATRA) has 14 years of Cash from Operations data on file, last reported at 3073000.0 in Q1 2026.

  • Quarterly Cash from Operations rose 89.08% year-over-year to 3073000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 25875000.0 (up 61.52% YoY) and the FY2025 annual result came in at 50940000.0, up 25.87% from the prior year.
  • Cash from Operations grew to 3073000.0 in Q1 2026, from 5697000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 3073000.0 in Q1 2026 to a low of 84529000.0 in Q1 2022.
  • A 5-year average of 34478647.06 and a median of 29612000.0 in 2024 frame the typical range for Cash from Operations.
  • Annual changes were most pronounced in 2024 — Cash from Operations soared 92.23% — and 2025, when it sank 145.35%.
  • Tracing ATRA's Cash from Operations over 5 years: stood at 56880000.0 in 2022, then grew by 11.38% to 50406000.0 in 2023, then surged by 51.45% to 24471000.0 in 2024, then soared by 76.72% to 5697000.0 in 2025, then jumped by 46.06% to 3073000.0 in 2026.
  • The last three Cash from Operations figures came in at 3073000.0 (Q1 2026), 5697000.0 (Q4 2025), and 9787000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.13 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 813.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -526.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 462.82 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 326.72 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 360.27 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -88.83 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 728.46 Mn
10 Atara Biotherapeutics 141.08 Mn 124.53 Mn 439,000.00 -3.34 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.34 Mn
Jun 30, 2026 -3.34 Mn
Mar 31, 2026 -3.07 Mn
Mar 31, 2026 -3.07 Mn
Dec 31, 2025 -5.70 Mn
Dec 31, 2025 -5.70 Mn
Sep 30, 2025 -9.79 Mn
Sep 30, 2025 -9.79 Mn
Jun 30, 2025 -7.32 Mn
Jun 30, 2025 -7.32 Mn
Mar 31, 2025 -28.14 Mn
Mar 31, 2025 -28.14 Mn
Dec 31, 2024 -24.47 Mn
Dec 31, 2024 -24.47 Mn
Sep 30, 2024 -3.99 Mn
Sep 30, 2024 -3.99 Mn
Jun 30, 2024 -10.65 Mn
Jun 30, 2024 -10.65 Mn
Mar 31, 2024 -29.61 Mn
Mar 31, 2024 -29.61 Mn